This document discusses value-based healthcare and consists of presentations from a DayOne Experts event on June 18, 2020. It explores why value-based healthcare is needed, how it is implemented, and who benefits from it. The event included breakout sessions on how COVID-19 could catalyze value-based approaches, how it may change disease treatment and research, its potential to trigger innovation and new business models, and how to define and measure healthcare value from the patient perspective.

1. © 2020 Basel Area Business & Innovation, all rights reserved.
DayOne Experts, June 18, 2020
Value Based Healthcare
Why is it needed? How is it done?
Who will benefit from it?

2. © 2020 Basel Area Business & Innovation, all rights reserved.
Thomas Brenzikofer, Co-Founder DayOne
Manager Networks & Events, Basel Area Business & Innovation

3. © 2020 Basel Area Business & Innovation, all rights reserved.
#DayOneBasel

4. DayOne is the
Healthcare Innovation
initiative managed by
Basel Area Business &
Innovation
© 2020 Basel Area Business & Innovation, all rights reserved.

5. Alain Bindels
Core team
© 2020 Basel Area Business & Innovation, all rights reserved.
Roche
Andre Moeri
Impact Hub
Basel
Andrea Huber-
Brösamle
ETH Zurich
Andreas Wicki
Kantonsspital
Baselland
Bejal Joshi
T4 Communications
Bhupinder Bhullar
Consultant
Bram Stieltjes
University
Hospital Basel
Christian Bosshard
CSEM
Christian Schneider
University Basel
Douglas Haggstrom
Basel Area Business
& Innovation
Enkelejda Miho
FHNW
Erik Schkommodau
FHNW
Fabian Streiff
Basel Area Business
& Innovation
Frank Kumli
Basel Area Business
& Innovation
Dr. Katrin Crameri
SPHN
Laurenz Baltzer
Karger
Publishing
Melissa Penny
Swiss TPH
Michael Rebhan
Novartis
Nicole Probst-
Hensch
Swiss TPH
Dr. Niko
Beerenwinkel
ETH Zürich,
D-BSSE
Rocco Falchetto
President Swiss
Society for
Porphyria
Peter Groenen
Idorsia
Thomas
Brenzikofer
Basel Area Business
& Innovation
Torsten Schwede
SIB
Viktor Bullain
Global coach
Giancarlo Covino
Helsana

6. Knowledge partners
In close
collaboration with
Supporting partners
Partners
<
<<<
<<
<<
<
<<<<
<

7. A
DayOne is on a mission to
Shape the future of health
A growing community of
1500+ healthcare innovators...

8. A
DayOne is on a mission to
Shape the future of health
…working together
to shape the future of health

9. 9

10. the future of health

17. value for the patient/citizen

18. © 2020 Basel Area Business & Innovation, all rights reserved.
Value based Healthcare

19. © 2020 Basel Area Business & Innovation, all rights reserved.
Barri Falk
Swiss Life Sciences Consulting Lead
Deloitte

20. © 2020 Basel Area Business & Innovation, all rights reserved.
Cost
The value based healthcare puzzle

21. © 2020 Basel Area Business & Innovation, all rights reserved.
Cost
The value based healthcare puzzle
12 % from
GDP

22. © 2020 Basel Area Business & Innovation, all rights reserved.
Cost
The value based healthcare puzzle
12 % from
GDP

23. © 2020 Basel Area Business & Innovation, all rights reserved.
Cost 12 % from
GDP
How much (more)
can we afford ?
The value based healthcare puzzle

24. © 2020 Basel Area Business & Innovation, all rights reserved.
Cost 12 % from
GDP
How much (more)
can we afford ?
 economic growth
 distribution of
income
The value based healthcare puzzle

25. © 2020 Basel Area Business & Innovation, all rights reserved.
Cost 12 % from
GDP
How much (more)
can we afford ? 0
The value based healthcare puzzle
 economic growth
 distribution of
income

26. © 2020 Basel Area Business & Innovation, all rights reserved.
Cost 12 % from
GDP
How much (more)
can we afford ?
 economic growth
 equality of
income 0
For what are
we willing to
pay?
The value based healthcare puzzle

27. © 2020 Basel Area Business & Innovation, all rights reserved.
Cost 12 % from
GDP
How much (more)
can we afford ?
 economic growth
 equality of
income 0
For what are
we willing to
pay?
What is the outcome
worth? What is the
outcome worth to me?
The value based healthcare puzzle

28. © 2020 Basel Area Business & Innovation, all rights reserved.
Cost 12 % from
GDP
How much (more)
can we afford ?
 economic growth
 equality of
income 0
For what are
we willing to
pay?
Value
The value based healthcare puzzle
What is the outcome
worth? What is the
outcome worth to me?

29. © 2020 Basel Area Business & Innovation, all rights reserved.
Michael E. Porter, Harvard Business School, 2009
“Value-based healthcare Delivery”
outcome / costs = value

30. © 2020 Basel Area Business & Innovation, all rights reserved.
Michael E. Porter, Harvard Business School, 2009
“Value-based healthcare Delivery”
outcome? / costs = value

31. © 2020 Basel Area Business & Innovation, all rights reserved.
Michael E. Porter, Harvard Business School, 2009
“Value-based healthcare Delivery”
Outcome?
 Survival = Years Gained
 Degree of Recovery, QoL

32. © 2020 Basel Area Business & Innovation, all rights reserved.
How much is a human life worth?

33. © 2020 Basel Area Business & Innovation, all rights reserved.
How much is a human life worth?
Value of a statistical life

34. Cost/value
2018: 6,5 Mio CHF
Source: https://nzzas.nzz.ch/schweiz/ein-leben-ist-bund-ploetzlich-fast-doppelt-so-viel-wert-ld.1401694?reduced=true
2013: 3,5 Mio CHF
2005: 1,5 Mio CHF

35. Cost/value
95 years
278 CHF
60 years
Cost Source: BFS – Kosten und Finanzierung des Gesundheitswesens, 2019
Age
8797 CHF

36. Cost/value
95 years
278 CHF
60 years
Cost
Age
8797 CHF
value of a statistical life 2018: 6,5 CHF; 6630/month

37. Cost/value
95 years
278 CHF
60 years
Cost
Age
8797 CHF
Value of a statistical life 2018: 6,5 CHF; 6630/month

38. Cost/value
95 years
278 CHF
60 years
Cost Source: World Bank development report 1993
Age
8797 CHFDALY – Disability Adusted Life Year Weight

39. Cost/value
95 years
278 CHF
60 years
Cost
Age
8797 CHFDALY – Disability Adusted Life Year Weight

40. © 2020 Basel Area Business & Innovation, all rights reserved.
Michael E. Porter, Harvard Business School, 2009
“Value-based healthcare Delivery”
Old New
Product = Treatment Product = Health
Measure = Volume Measure = Value
etc. etc.

41. © 2020 Basel Area Business & Innovation, all rights reserved.
Michael E. Porter, Harvard Business School, 2009
“Value-based healthcare Delivery”
Old New
Product = Treatment Product = Health
Measure = Volume Measure = Value
etc. etc.

42. © 2020 Basel Area Business & Innovation, all rights reserved.
AGENDA
16.00 – 16.20
Welcome with Barri Falk, Deloitte
& Introduction
Thomas Brenzikofer
Basel Area Business & Innovation
16.20 – 16.40 The Big Picture Elizabeth Hampson, Deloitte
16.40 – 16.50 Industry view Michael Rebhan, Novartis
16.50 – 17.00 Startup View Michel Mohler, Lyfegen
17.00 – 17.10 Healthcare Provider View
Florian Rüter, University Hospital of
Basel
17.15 – 17.45
Moderated deep dive sessions with
speakers in parallel in separate virtual
rooms
Moderation: Thomas Nürnberger,
Douglas Häggström, Fabian Streiff
17.45 – 18.15 Feedback, Wrap up and Outlook Speakers

43. Breakout 1: How will Covid-19 catalyze the value based healthcare
aproach? – with Elizabeth Hampson, Deloitte – Moderation: Thomas
Nürnberger, Basel Area Business & Innovation
Breakout 2: How will Value Based Healthcare change the way we look
at the disease/health-continuum and research & develop new
treatments? – with Michael Rebhan, Novartis – Moderation: Thomas
Brenzikofer, Basel Area Business & Innovation
Breakout 3: Will Value Based Healthcare trigger innovation and new
business models? – with Michel Mohler, Lyfegen – Moderation: Douglas
Häggström, Basel Area Business & Innovation
Breakout 4: How to define value, how to measure value of healthcare
and what is the patient’s role? – with Florian Rüter, University Hospital of
Basel – Moderation: Fabian Streiff, Basel Area Business & Innovation

44. Workshop this afternoon
Breakouts
1- Covid-19 – Elisabeth Hampson 3 – Start-ups – Michel Mohler
2- Industry/R&D – Michael Rebhan
4 – Healthcare Provider –
Florian Rüter
How you check in to the room of your choice
 Please change your user name Example: 6 2 3 Stefano
Glauser (DayOne) the best we can to accommodate the choic
Add the number of the
breakout session:
“2 Thomas Brenzikofer”

45. © 2020 Basel Area Business & Innovation, all rights reserved.
Elizabeth Hampson
Director Health Innovation Strategy, Deloitte (UK)

46. Breakout 1: How will Covid-19 catalyze the value based healthcare
aproach? – with Elizabeth Hampson, Deloitte – Moderation: Thomas
Nürnberger, Basel Area Business & Innovation
Breakout 2: How will Value Based Healthcare change the way we look
at the disease/health-continuum and research & develop new
treatments? – with Michael Rebhan, Novartis – Moderation: Thomas
Brenzikofer, Basel Area Business & Innovation
Breakout 3: Will Value Based Healthcare trigger innovation and new
business models? – with Michel Mohler, Lyfegen – Moderation: Douglas
Häggström, Basel Area Business & Innovation
Breakout 4: How to define value, how to measure value of healthcare
and what is the patient’s role? – with Florian Rüter, University Hospital of
Basel – Moderation: Fabian Streiff, Basel Area Business & Innovation

47. Workshop this afternoon
Breakouts
1- Covid-19 – Elisabeth Hampson 3 – Start-ups – Michel Mohler
2- Industry/R&D – Michael Rebhan
4 – Healthcare Provider –
Florian Rüter
How you check in to the room of your choice
 Please change your user name Example: 6 2 3 Stefano
Glauser (DayOne) the best we can to accommodate the choic
Add the number of the
breakout session:
“2 Thomas Brenzikofer”

48. © 2020 Basel Area Business & Innovation, all rights reserved.
DayOne Experts, June 18, 2020
Value Based Healthcare
Why is it needed? How is it done?
Who will benefit from it?

49. Thank you
Follow us at
www.dayone.swiss
DayOne is the Healthcare Innovation initiative managed by
Basel Area Business & Innovation